Novavax
NVAX
$48.00
Share price
-7.50%
Change (1 day)
-65.75%
Change (1 year)
Categories
Earnings for Novavax (NVAX)
Earnings in 2021 (TTM): -$1.7 B
According to Novavax's latest financial reports the company's current earnings (TTM) are -$1.7 B. In 2020 the company made an earning of -$0.41 B a decrease over its 2019 earnings that were of -$0.13 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Novavax from 2001 to 2021
| Year | Earnings | Change |
|---|---|---|
| 2021 (TTM) | -$1.7 B | 320.08% |
| 2020 | -$0.41 B | 234.52% |
| 2019 | -$0.13 B | -30.17% |
| 2018 | -$0.18 B | 1.69% |
| 2017 | -$0.17 B | -36.44% |
| 2016 | -$0.27 B | 70.4% |
| 2015 | -$0.16 B | 89.27% |
| 2014 | -$0.09 B | 59.83% |
| 2013 | -$0.06 B | 81.9% |
| 2012 | -$0.03 B | 50.5% |
| 2011 | -$0.02 B | -47.66% |
| 2010 | -$0.04 B | -3.3% |
| 2009 | -$0.04 B | 8.8% |
| 2008 | -$0.04 B | 13.51% |
| 2007 | -$0.04 B | 23.01% |
| 2006 | -$0.03 B | 168.31% |
| 2005 | -$9.18 M | -62.51% |
| 2004 | -$0.03 B | 52.4% |
| 2003 | -$0.02 B | -25.54% |
| 2002 | -$0.03 B | 132.94% |
| 2001 | -$9.26 M |